Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Mucoadhesive Gels in Controlling Gag Reflex Among Children During Dental Radiographic Examination

NCT07509918 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-09-01
Last updated
2026-04-08

Condition(s) studied

Gag ReflexChild

Investigational drug(s) / intervention(s)

Tannic Acid Mucoadhesive Gel (Topical)Zinc Acetate Mucoadhesive Gel (Topical)Lidocaine Gel (Topical) →

Tannic Acid Mucoadhesive Gel (Topical): A mucoadhesive gel containing tannic acid at a specified concentration is applied topically to the oral mucosa prior to the dental procedure. The gel is intended to reduce gag reflex through its astringent and protein-precipitating properties.

Zinc Acetate Mucoadhesive Gel (Topical): A mucoadhesive gel containing zinc acetate at a specified concentration is applied topically to the oral mucosa before the dental procedure. The formulation is used to evaluate its potential effect in reducing gag reflex.

Lidocaine Gel (Topical): A topical lidocaine gel at an appropriate concentration is applied to the oral mucosa prior to the dental procedure as a standard local anesthetic agent for gag reflex suppression.

Study summary

This randomized clinical trial compares tannic acid-zinc acetate mucoadhesive gel with lidocaine gel for reducing gag reflex in children aged 8-10 years during radiographic dental examination Gag reflex severity and pulse rate will be assessed before and after gel application. The study evaluates the effectiveness of the tested gel as a potential alternative to lidocaine.

Eligibility

Sex
ALL
Min age
8 Years
Max age
10 Years
Healthy volunteers
Accepted
Inclusion Criteria: * The study will include children aged between 8 and 10 years . * Pediatric dental patients requiring intraoral radiographs for diagnostic or treatment purposes will be recruited. * Children present with a fully erupted maxillary last molar to allow standardized placement of the radiographic film for gag reflex stimulation. * Written informed consent will be obtained from parents or legal guardians before participation. Exclusion Criteria: * Children with systemic diseases or neurological disorders that may influence gag reflex,such as epilepsy or cerebral palsy. * Those with a history of allergies to the materials that will be used in the study gels are not considered eligible. * Patients with acute respiratory infections, oropharyngeal inflammation, or enlarged tonsils at the time of the examination are excluded to avoid confounding variables. * Children taking medications known to modify gag reflex or pulse rate, such as sedatives or antihistamines, are not included. * Uncooperative or extremely anxious children, classified as Frankl ratings 1 or 2, are excluded

Primary outcome measure(s)

  • Gag reflex severity score using a 5-point Likert faces scale — Immediately after gel application during the dental procedure (single visit)
    Gag reflex severity is assessed using a 5-point Likert faces scale (score range: 0-5), where higher scores indicate greater gag reflex severity, following application of the assigned topical gel during the dental procedure.

Trial sites (1)

FacilityCityRegionStatus
Faculty of dentistry Cairo university Cairo Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07509918 on ClinicalTrials.gov ↗ ← All trials in Egypt